Summary of resources, abbreviations and acronyms
| Acronym | Full name | Description |
| ANCHOR | Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration | Phase 3 clinical trial in age-related macular degeneration |
| BRAVO | Ranibizumab for the treatment of Macular Oedema Following Branch Retinal Vein Occlusion: Evaluation of Efficacy and Safety Trial | Phase 3 clinical trial in Branch Retinal Vein Occlusion (BRVO) |
| CIGTS | Collaborative Initial Glaucoma Treatment Study | Medical versus surgical therapy trial in open-angle glaucoma |
| COMET | Core Outcome Measures in Effectiveness Trials | An initiative to bring together people interested in the development and application of agreed standardised sets of outcomes, known as COS |
| COS | Core Outcome Sets | An agreed minimum set of outcomes or outcome measures to be collected in all clinical studies of a particular condition |
| COSMIN | Consensus-Based Standards for the Selection of Health Measurement Instruments | An initiative to improve the selection of health measurement instruments |
| CRUISE | Central Retinal Vein Occlusion Study: Evaluation of Efficacy and Safety Trial | Phase 3 clinical trial in Central Retinal Vein Occlusion (CRVO) |
| EAGLE | Effectiveness of Early Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma | Surgical trial in primary angle-closure glaucoma |
| FILMS | Full-Thickness Macular Hole and Internal Limiting Membrane Peeling Study | Surgical trial in macular-hole repair |
| FVQ CYP | Functional Vision Questionnaire for Children and Young People | Questionnaire for the measurement of visual function in children and young people |
| HTA | Health technology assessment | The systematic evaluation of the properties, effects and/or impacts of a health technology |
| ICHOM | International Consortium for Health Outcomes Measurement | An initiative to try to measure and report patient outcomes in a standardised way |
| ISOQOL | International Society for Quality of Life Research | An initiative to advance the study of health-related quality of life and other patient-centred outcomes |
| IVAN | Inhibition of VEGF in Age-Related Choroidal Neovascularization | Randomised controlled trial in age-related macular degeneration |
| MacDQol | Macular Disease on Quality of Life | An individualised measure of the impact of macular disease on quality of life |
| MARINA | Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular AMD | Phase 3 clinical trial in age-related macular degeneration |
| MUST | Multicentre Uveitis Steroid Treatment | Phase 4 clinical trial in uveitis |
| NEI VFQ-25 | National Eye Institute Visual Functioning Questionnaire 25 | Questionnaire for the measurement of visual function in adults |
| PREM | Patient-reported experience measure | A measurement instrument by which patients assess their experience of one or more aspects of their healthcare |
| PROM | Patient-reported outcome measure | A measurement instrument by which patients assess their own health status, which may include symptoms, functionality and other aspects of physical, mental and social health |
| PROQOLID | Patient-Reported Outcome Quality of Life Instruments Database | A database of patient-centred clinical outcome assessments |
| PSS | Patient Support Society | An organisation that exists to support patients, usually outside the healthcare institutions |
| RESTORE | Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema | Phase 3 trial in diabetic macular oedema |
| VAQ | Visual Activities Questionnaire | Questionnaire of visual function in adults |
| VQoL_CYP | Vision-Related Quality-of-Life Instrument for Children and Young People | Questionnaire for the measurement of vision-related quality of life in children and young people |